Skip to main content

Articles

Biosimilar to Trastuzumab Shows Equivalent Efficacy and Safety

Novel Vaccine Induces Immunologic Responses in Patients with Acute Myeloid Leukemia

New Standard in Elderly Patients with Glioblastoma Based on Phase 3 Evidence

Novel Chimeric Monoclonal Antibody Improves Survival in Advanced Gastric Cancers

Adding the BCL-2 Inhibitor Venetoclax to Treatment Regimen Promising in Relapsed or Refractory Multiple Myeloma

In the Literature, Prostate Cancer, Oncology

In the Literature - August 2016

Healthcare Resource Utilization High in Patients with Relapsed or Refractory Multiple Myeloma

Where Quality Meets Cost: Payers’ Perspective on Pathways

Costs of Treatment-Related Adverse Events Higher with Docetaxel than with Nivolumab in Advanced Lung Cancer

Cost of Chemotherapy for Breast Cancer Varies Widely Across Regimens

Page 108 of 244
Results 1071 - 1080 of 2439